Tag: pharmaceuticals
-
Trial Shows Nasal Vaccine Reduces Whooping Cough Bacteria
Results of a clinical trial show a vaccine delivered as a nasal spray protects healthy people against infection from the bacteria causing whooping cough infections.
-
What Science Has to Say About CBD
If you’ve used CBD for these reasons above, you might enjoy peace of mind knowing scientists have found the possible benefits you’ve known all along.
-
Trial Begins for Multi-Neurological Disease Therapy
A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders.
-
Grant Funds Typhoid Vaccine Patch Development
A health research foundation grant is funding development of a vaccine protecting against typhoid fever, given in a patch from from a spring-loaded device.
-
HHS Directs $100M for Covid-19 Venture Investments
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19.
-
Company Gains Ultrasound-Linked Drug Capsule Technology
A company developing a drug delivery process with treatments activated by ultrasound received an option to license a key technology from its founders’ university labs.
-
Biotech, A.I. Companies Model Animal Studies/Clinical Trials
A discoverer of neuroscience therapies and a genomics data science company are developing machine learning models to predict clinical trial outcomes for ADHD drugs.
-
Trial Underway Testing Stem Cell Particles for Burns
A clinical trial has begun testing an experimental treatment for burns using off-the-shelf therapeutic particles derived from human bone marrow stem cells.
-
Industry, Univ. Labs Partner on Parkinson’s Digital Biomarkers
A developer of electronic health data tools and a university’s neuroscience labs are collaborating on tests of Parkinson’s disease drugs using digital measures of patient functioning.
-
Regeneron Acquires Hearing Loss Biotech in $213M Deal
Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders.